scholarly journals The evolution of the loss of life expectancy in patients with chronic myeloid leukaemia: a population‐based study in the Netherlands, 1989–2018

2021 ◽  
Author(s):  
Carolien C. H. M. Maas ◽  
David Klaveren ◽  
Geneviève I. C. G. Ector ◽  
Eduardus F. M. Posthuma ◽  
Otto Visser ◽  
...  
Keyword(s):  
Life Expectancy ◽  
The Netherlands ◽  
Chronic Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Population Based ◽  
Population Based Study ◽  
Loss Of Life

scholarly journals Quality of life among people living with HIV in England and the Netherlands: a population-based study

2021 ◽  
Vol 8 ◽  
pp. 100177
Author(s):  
Stephanie Popping ◽  
Meaghan Kall ◽  
Brooke E. Nichols ◽  
Evelien Stempher ◽  
Lisbeth Versteegh ◽  
...  
Keyword(s):  
Quality Of Life ◽  
The Netherlands ◽  
Population Based ◽  
People Living With Hiv ◽  
Population Based Study ◽  
Living With Hiv

Use of Primary Radiotherapy for Rectal Cancer in the Netherlands between 1997 and 2008: A Population-based Study

2012 ◽  
Vol 24 (1) ◽  
pp. e1-e8 ◽  
Author(s):  
J.J. Jobsen ◽  
M.J. Aarts ◽  
S. Siesling ◽  
J. Klaase ◽  
W.J. Louwman ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
The Netherlands ◽  
Population Based ◽  
Population Based Study ◽  
Primary Radiotherapy

scholarly journals Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study

2012 ◽  
Vol 30 (24) ◽  
pp. 2995-3001 ◽  
Author(s):  
Malin Hultcrantz ◽  
Sigurdur Yngvi Kristinsson ◽  
Therese M.-L. Andersson ◽  
Ola Landgren ◽  
Sandra Eloranta ◽  
...  
Keyword(s):  
General Population ◽  
Life Expectancy ◽  
Excess Mortality ◽  
Myeloproliferative Neoplasms ◽  
Treatment Options ◽  
Large Population ◽  
Relative Survival ◽  
Population Based ◽  
Population Based Study ◽  
Over Time

PurposeReported survival in patients with myeloproliferative neoplasms (MPNs) shows great variation. Patients with primary myelofibrosis (PMF) have substantially reduced life expectancy, whereas patients with polycythemia vera (PV) and essential thrombocythemia (ET) have moderately reduced survival in most, but not all, studies. We conducted a large population-based study to establish patterns of survival in more than 9,000 patients with MPNs.Patients and MethodsWe identified 9,384 patients with MPNs (from the Swedish Cancer Register) diagnosed from 1973 to 2008 (divided into four calendar periods) with follow-up to 2009. Relative survival ratios (RSRs) and excess mortality rate ratios were computed as measures of survival.ResultsPatient survival was considerably lower in all MPN subtypes compared with expected survival in the general population, reflected in 10-year RSRs of 0.64 (95% CI, 0.62 to 0.67) in patients with PV, 0.68 (95% CI, 0.64 to 0.71) in those with ET, and 0.21 (95% CI, 0.18 to 0.25) in those with PMF. Excess mortality was observed in patients with any MPN subtype during all four calendar periods (P < .001). Survival improved significantly over time (P < .001); however, the improvement was less pronounced after the year 2000 and was confined to patients with PV and ET.ConclusionWe found patients with any MPN subtype to have significantly reduced life expectancy compared with the general population. The improvement over time is most likely explained by better overall clinical management of patients with MPN. The decreased life expectancy even in the most recent calendar period emphasizes the need for new treatment options for these patients.

Primary therapy and survival in patients with Burkitt lymphoma in the Netherlands: a population-based study, 1989-2018

Blood ◽  
2021 ◽  
Author(s):  
Djamila Issa ◽  
Rianne Lieke Seefat ◽  
Otto Visser ◽  
Sonja Zweegman ◽  
Pieternella J Lugtenburg ◽  
...  
Keyword(s):  
The Netherlands ◽  
Burkitt Lymphoma ◽  
Population Based ◽  
Primary Therapy ◽  
Population Based Study
Sign in / Sign up

Export Citation Format

Share Document